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Abstract 
Objective To investigate the characteristics, methodological qu lity, and reporting of 
statistical analyses of published dose-response meta-analyses (DRMAs). 
Study Design and Setting We searched PubMed to identify DRMAs published in 2017. The 
reporting characteristics and methodological qualities were assessed by the PRISMA (27 
items) and AMSTAR (11 items) respectively. We also summarized the reporting of statistical 
analyses of included DRMAs. 
Results We identified 93 DRMAs, most of which (59/93) were conducted by Chinese 
researchers, the main outcome was the incidence of ancers. Of the PRISMA and AMSTAR 
items, twenty and five were well complied (80% or more) respectively. The compliance rates 
of several PRISMA checklist items, such as structured summary, objectives, protocol and 
registration, and funding, were less than 50%. There were no criteria to estimate the doses for 
the open-ended intervals of exposure or intervention d ses. When the restricted cubic splines 
were used to fit nonlinear dose-response relationshps, there were also no criteria to determine 
the fixed knots. 
Conclusion The adherence to the methodological items of reporting guidelines and statistical 
analysis of published DRMAs were suboptimal. Development of reporting guidelines to assist 
authors in writing and readers in critically appraising the reports of DRMAs is timely. 
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An increasing number of dose-response meta-analyses (DRMAs) have been published over 
the past several years[1]. When we research on observed associations between exposure and 
outcome, dose-response relationship is an important factors affecting the convincingness of 
clinical epidemiological evidence [2]. DRMAs were able to yield more precise estimates of 
putative dose-response effects when dose-specific findings from different studies on the same 
subjects were reported. 
Generally, dose-response relationship may be linear or non-linear. Linear dose-response 
analyses are performed by fitting generalized least squares for trend (GLST)[3] model. There 
are generally three types of functions for fitting the nonlinear dose-response relationship: 
restricted cubic splines, natural quadratic function, and the fractional polynomials [4, 5]. The 
most common nonlinear function is the restricted cubi  splines with 3 or 4 knots inserted in 
the data distribution.  
Although DRMAs was a type of meta-analyses quantitatively synthesizing results of 
multiple original studies, the statistical analysis of DRMAs may be particularly different from 
traditional meta-analyses [6-11]. A comprehensive appr isal evaluating the reporting 
characteristics, methodological quality, and statistical analysis of published DRMAs is 
imperative but reporting guidelines for DRMAs is lacking. Recently, Xu et al. [12, 13] 
assessed 529 DRMAs published from January 2011 to July 2017 , using the PRISMA 
















(Meta-analysis of Observational Studies in Epidemiology)[15], and AMSTAR (A 
Measurement Tool to Assess Systematic Reviews)[16]. However, currently there are no 
studies that have assessed the reported statistical analysis of DRMAs. The availability of such 
information is also critical for the development of reporting guidance for DRMAs, because it 
is possible that the reporting quality of DRMAs might be improved over time [17].  
Therefore, we conducted a methodological review of DRMAs published in 2017, to 
summarize their characteristics and methodological qu ity based on the AMSTAR (11 items) 
and the PRISMA (27 items) respectively. And to investigate the key statistical analysis 
reported in recently published DRMAs. 
2. Methods 
2.1. Eligibility criteria 
We included meta-analyses that explicitly combined dose-response estimates from multiple 
original studies on the same subjects and reported the results of dose-response analyses. Brief 
reports (i.e. a short demonstration of research results), letter, and conference abstracts were 
excluded since such type of publication contained limited information of reporting items.   
2.2. Literature Search  
We searched PubMed to identify DRMAs published from January 1st, 2017 to December 
31st, 2017, using the following search strategy: ((meta-analysis [Title/Abstract]) AND 
dose-response [Title/Abstract]) AND ("2017/1/1"[Date - Publication]: "2017/12/31"[Date - 
















2.3. Study selection 
Literature search records were imported into the literature management software of 
ENDNOTE X7. Two independent reviewers (QJ and QL) examined the title and abstract of 
retrieved records to identify potentially relevant DRMAs according to the eligibility criteria. 
Then, full-text versions of all potentially relevant DRMAs were obtained to further confirm 
the eligibility. By systematic sampling, renumbered all articles: 001, 002, ... 186 and divided 
into 93 groups of 2 numbers each. Randomly selected a number “t” in the first part 001, 002, 
and then selected all “t + 2k” (k = 0, 1, 2, ... 92) to obtain a sample with a capacity of 93. 
Disagreements between the two reviewers were resolvd by discussing with a third reviewer 
(SC). 
2.4. Data extraction 
We collected data from included DRMAs on general chracteristics, including countries of 
corresponding author, categories of study outcome, database searched, the key reporting 
(PRISMA) and methodological (AMSTAR) components, and specific items about the 
statistical analyses of dose-response effects. A standard data abstraction form was created 
using Microsoft Excel 2013 (Microsoft Corp, Redmond, WA, www.microsoft.com) .Two 
investigators (QJ, QL) independently extracted the data. Any disagreements were resolved by 
discussion.  
2.5. Data analyses 
General characteristics of included DRMAs were summarized descriptively. Since no 
















methodology quality according to PRISMA and AMSTAR. We used the AMSTAR [16]to 
assess the methodological quality of the include DRMAs. The PRISMA statement is a 
checklist of 27 items that are recommended to be included in systematic reviews and 
meta-analyses to ensure that published reports contain all relevant information[14]. Each 
PRISMA item was rated with a ‘‘yes’’ or ‘‘no’’ response. A ‘‘yes’’ response means that the 
item was reported, and a ‘‘no’’ response means that the item was not reported. The AMSTAR 
tool is an 11-item questionnaire that is used to deermine the methodological of systematic 
reviews and meta-analyses[16]. The original tool had four responses with each item, ‘‘yes,’’ 
‘‘no,’’ ‘‘cannot answer,’’ or ‘‘not applicable’’. As we included only meta-analyses, every item 
was applicable. A ‘‘yes’’ response means that the iem is fulfilled, a “no’’ response means that 
the item is not fulfilled, and a ‘‘cannot answer’’ response means that it is inconclusive as to 
whether the item is fulfilled. In this study, we assigned “1” to “yes” response, and “0”to “no” 
or “cannot answer” response for each of the PRISMA and AMSTAR items. Therefore, every 
included DRMA has an overall PRISMA counts rated out of a maximum point of 27, and 
every included DRMA has an overall AMSTAR counts rated out of a maximum point of 11.  
We calculated the adherence rates of individual AMSTAR and PRISMA items and showed 
results in figures. The calculation formula was as follows: adherence rate of an item = (the 
number of articles with a “yes” response to the item/ the total number of articles)*100%. The 
AMSTAR and PRISMA counts of each article were also calculated.  
To investigate the statistical analyses process of the included DRMAs, we descriptively 
















effects, and knots used when restricted cubic splines were employed. 
3. Results  
3.1. Literature search  
Initial literature search retrieved 292 citations. After removing duplicates and the 
title/abstracts screening, 248 publications were colle ted for the full text screening. We 
excluded articles that did not explicitly combine dose estimates from multiple original studies 
on the same subjects, or did not report results of dose-response analyses. Finally, through a 

















Fig.1 The Flow chart of literature selection. 
3.2. General characteristics of included DRMAs 
China was the most common country in which the included DRMAs were conducted 
(59/93, 63.4%), followed by Germany (6/93, 6.5%) and Italy (5/93, 5.4%) (Fig.2). Cancer 
(31/93, 33.3%) was the most common disease outcome in th  included DRMAs (Fig.3). 
















was frequently combined with a search of EMBASE (64/93, 68.8%). The details of databases 
searched are shown in Table 1. 
3.3. Reporting quality based on PRISMA 
The highest and lowest scores for a single article based on PRISMA were 26 and 17, and 
the average score and corresponding standard deviation were 22.83 and 1.96. About half of 
PRISMA items (13/27, 48.2%) were reported in the included DRMAs. 48.4% of DRMAs 
provided a structured summary and only 6.5% provided an explicit statement of questions 
being addressed with reference to participants, interventions, comparisons, outcomes, and 
study design (PICOS). 48.4% of DRMAs provided registration information on review 
protocols. 52.7% of DRMAs described methods used for assessing risk of bias of individual 
studies and 75.3% considered impact of possible risk of bias on the cumulative evidence (e.g., 
publication bias, selective reporting, and so on). In addition, 36.6% of DRMAs described 
sources of funding for the systematic review and other support. The percentages of adequately 


















Fig.2. Countries of included dose-response meta-analyses. 
 
Fig.3. Categories of outcome of included dose-respon e meta-analyses. 





Name of database 
searched 
PubMed/Medline 91 97.85 
Embase 70 75.27 
Web of Science 38 40.86 
Cochrane library 23 24.73 
Scopus 11 11.83 
Ovid 8 8.6 
















CNKI 7 7.53 
Wanfang 7 7.53 




PubMed/Medline + EMBASE 64 68.82 
PubMed/Medline + Web of Science 52 55.91 
PubMed/Medline + Embase + Web of 
Science 
46 49.46 
PubMed/Medline + Embase + Cochrane 
Library  
22 23.66 
PubMed/Medline + Embase + Google 
Scholar 
19 20.43 
PubMed/Medline + Web of Science + 
Cochrane Library 
16 17.2 
PubMed/Medline + Web of Science + 




Fig.4. The percentage of adequately reported individual items based on PRISMA. 
3.4. Methodological quality based on AMSTAR 
















highest and lowest AMSTAR scores were 11 and 5, and the average score and corresponding 
standard deviation were 8.40 and 1.60. Of the included DRMAs, 53.8% provided an “a priori” 
design, about one third did not perform a comprehensiv  literature search. Only 39.8% used 
the status of publications (i.e. grey literature) as an inclusion criterion. More than half of the 
included DRMAs considered the scientific quality and the conflict of interest in formulating 
conclusions, and assessed the likelihood of publication bias. 
 
Fig.5. The percentage of adequately reported individual items by AMSTAR. 
3.5. Statistical analysis of dose-response effects 
The statistical reporting in dose-response meta-analysis is shown in Table 2. For the 
corresponding RR, approximately half of the included DRMAs (44/93, 47.3%) assigned the 
















midpoint as the dose when studies reported the exposure by range. When the highest category 
was open-ended, the most common method (42/93, 45.2%) to assign the dose was the sum of 
the low end of the interval plus half of the width of the adjacent category. When the lowest 
category was open-ended, 38(40.9%) of the included DRMAs assumed the dose to be half of 
the high end of the interval, 14(15.1%) set the lowest boundary as zero, and 41(44.1%) did 
not mention the method used. 
When it comes to dose-response assessment, 69.9% and 76.3% of the included DRMAs 
assessed linear and non-linear relationships respectively. Half of the included DRMAs used 
the restricted cubic splines with fixed knots to assess the potential nonlinear dose-response 
effects. The most common knots adopted (32/47, 68.1%) were 10th, 50th, and 90th percentiles, 
followed by 5th, 35th, 65th and 95th percentiles (9/47, 19.2%). Almost half of the included 
DRMAs (45/93, 48.4%) assessed the indication of non-linearity. Dose-response plots were not 























Was the median or mean dose of exposure for each category was 
assigned to the corresponding RR for every study? (yes) 
44  47.31  
For studies reporting the exposure by range, was the midpoint of the 
range used as the dose? (yes) 
53  56.99  
If the highest category was open-ended, how to confirm the dose?     
   
The dose was assigned as 20% higher than the low end of the 
interval.  
4 4.30 
   
The dose was assigned as 25% higher than the low end of the 
interval.  
3  3.20  
   
The dose was assigned as 50% higher than the low end of the 
interval.  
5  5.34  
   
The dose was assigned as the sum of the low end of the interval 
plus half of the width of the adjacent category 
42 45.20  
   
The dose was calculated as the lower bound plus 1.5 times the 
width of the adjacent category. 
1  1.10  
   Not mentioned. 38  40.86  
If the lowest category was open-ended, how to confirm the dose?     
  The dose was assigned as half of the high end of the in erval.  38  40.86  
  The lowest boundary was set at zero. 14  15.05  
  Not mentioned. 41  44.09  
Dose-response assessment     
  Was the linear dose-response relation assessed? (yes) 65  69.90  
  Was the nonlinear association assessed? (yes) 71  76.34  
  Were both the linear and nonlinear association assessed? (yes) 45  48.39  
  Neither the linear nor the nonlinear association was mentioned. 12  12.90  
  
Was the potential nonlinear dose-response relationsh p assessed 
using restricted cubic splines with fixed knots? 
47  50.54  
If the potential nonlinear dose-response relationship was assessed using 
restricted cubic splines with fixed knots, the knots were: 
47  50.54 
  5th, 35th, 65th and 95th percentiles 9  19.15  
  25th, 50th, and 75th percentiles 3  6.38  
  10th, 50th, and 90th percentiles 32  68.09  
  5th, 50th and 95th percentiles 1  2.13 
  First, 25th, 50th, 75th, and 99th percentiles 1  2.13  
  10th, 60th, and 90th  percentiles 1  2.13  


















4.1. Summary of findings 
Generally speaking, the overall adherence rates of the PRISMA and AMSTAR were 
relatively suboptimal. Findings from our study demonstrated that there were deficiencies in 
methodological compliance and statistical analysis methods in published DRMAs. 
Development of reporting guidelines on DRMA is required to assist authors in writing and 
readers in critically appraising the reports of DRMAs.  
4.2. The strengths and limitations of reporting quality  
In our study, abstracts of the included DRMAs were not comprehensive. Almost half of the 
DRMAs lacked a structured summary, making it impossible for researchers to understand 
research content comprehensively and intuitively from the abstract. Due to no requirements 
for some magazines in structured abstracts, authors might fail to provide it. Less than one 
tenth of the included DRMAs provided an explicit statement of questions being addressed 
with reference to participants, interventions, comparisons, outcomes, and study design 
(PICOS). Majority of DRMAs did not provide the information about protocol and registration. 
Relevant research results showed that prospective regist ation could effectively improve the 
overall methodological quality of systematic reviews, and it could slightly improve overall 
reporting quality [18]. Protocol registration reduced the risk of multiple reviews addressing 
the same research question, identified publication b as, and provided greater transparency 
















when updating systematic reviews [19] and avoided duplication of effort [20]. Hence, it is 
necessary to treat preregistration as a mandatory checkpoint for future meta-analyses to be 
published. It is a promising measure worth researchers’ attention which might lead to a 
significant improvement of quality.  
Meta-analyses regularly have the intrinsic limitation of heterogeneity and conclusions 
could be misleading because of the additional analyses. Most of the meta-analyses did report 
the quantified heterogeneity using I2 value or other tests, the source of heterogeneity was not 
routinely explored. Subgroup analysis and meta-regression can be performed to explain the 
source of the significant heterogeneity [21, 22]. The interaction between the subgroups was 
one of the issues to be considered in the quality of meta-analysis, while the dose-response 
meta-analysis currently has no effective means for detection and adjustment.  
About a third of DRMAs described sources of funding and other support (e.g., supply of 
data), as well as the roles of funders. The sources of the funding and the conflict of interests 
had an obvious impact on the results of the research. Giving information about funds can help 
users better identify them, it needs to be reported explicitly in all studies. Not reporting risk of 
bias assessment may be due to a lack of good quality assessment tools for dose-response 
studies. 
4.3. The strengths and limitations of methodological quality  
The overall AMSTAR adherence rate was suboptimal, some methodological flaws were 
emerged. It was not hard to understand that ‘‘a priori’’ design can make sure the researchers 
















partially obligate the authors from post hoc modificat on of inclusion criteria and analytic 
methods [10]. Approximately one third of the included DRMAs did not perform a 
comprehensive literature search. There may be good rounds for only using major database 
searching without grey literature in DRMAs. Avoiding research on questionable quality, 
which may led to the low percentage of AMSTAR results. Perfect retrieval is reflected in two 
aspects: first, the elements of retrieval strategy should be complete; second, the scope of 
retrieval should be wide. Suboptimal compliance of item 4should also be noted, since 
exclusion of gray literature from meta-analyses can le d to exaggerated estimates of 
intervention effectiveness [7]. AMSTAR item 5 (list of studies) were underreported, it gave 
partial search strategies such as keywords used as MESH terms. Part of the reason was that 
authors only considered the lists of included studies and neglected the lists of important 
excluded studies[23].  
The majority of the included DRMAs assessed and documented the scientific quality. The 
scientific nature of a single study can affect the ov rall outcomes, and the quality grade of the 
original literature directly reflected the strength of evidence in systematic review. So the 
scientific nature of individual research needs to be further improved. It is reasonable to 
develop a methodological guideline of DRMA to help authors to form a clear thinking 
pathway. 
4.4. Developing a reporting guideline specifically for DRMAs  
There were no generally accepted methods to estimate doses for open-ended highest or 
















the original studies, and if not provided, the median of the extracted dose interval should be 
used instead. For the open interval of the end, it is usually necessary to make an estimate or 
hypothesis. Such as taking 1.2 or 1.5 times the cut-off point as the specified dose for the 
interval, or assuming the same width as the adjacent interval and then taking the median. In 
our research, the methods used for interval selection and dose determination s were 
inconsistent or unclear. When the highest category was open-ended, it was often to assign the 
sum of the low end of the interval plus half of thewidth of the adjacent category as the dose. 
On the other hand, when the lowest category was open-ended, many DRMAs assumed the 
dose to be half of the high end of the interval. There were also doses specified as 20%, 25% 
and 50% higher than the low end of the interval, respectively. The dose-response mapping 
process was generally fitted by a restricted cubic spline method, defining a smooth inflection 
point in the curve fit as a knot. Using an insufficient number of knots is difficult to show 
detailed changes in the dose response, and using too many knots will result in imprecise 
fitting. Therefore, 3 or 4 knots were generally used in the dose response mapping[5]. There 
were several different methods for knots selection, including 5th, 35th, 65th and 95th 
percentiles, as well as 10th, 50th, and 90th percentiles. There was also a lack of criteria to 
determine the fixed knots that assessing restricted cubic splines when it comes to nonlinear 
dose-response relationship. 
The complex nature of statistical analysis of DRMAs rai ed the necessity to develop a 
guideline about the reporting of statistical analysis of DRMAs. The authors may have used the 
















research process record. The figures and tables related to the dose-response should also be 
presented in the article. In addition, having a repo ting guideline makes the peer review 
process more efficient and more informed.  
Overall, The adherence to the methodological items of reporting guidelines and statistical 
analysis of published DRMAs were suboptimal. Some methodological flaws had been 
identified in the published DRMAs, especially regarding to the priority design, 
comprehensive literature search and the status of publications. Meanwhile, some 
shortcomings in reporting quality had also come to light, particularly about the structured 
summary, objectives, protocol and registration. Further improvement could potentially be 
achieved by strictly adhering to PRISMA guideline and having “a priori” protocol. We 
propose to develop a reporting guideline specifically for DRMAs, with relevant criteria to 
define the dose for the open-ended intervals, and explicitly fixed knots to assess restricted 
cubic splines when it comes to nonlinear dose-respon e relationship.  
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What is new? 
Key findings  
 The methodological quality and statistical analysis of published 
DRMAs were suboptimal. The compliance rates of several PRISMA 
or AMSTAR checklist items, such as structured summary, objectives, 
funding, protocol and registration, and status of publication, were less 
than 50%.  
 In these included DRMAs, there were no consistent criteria to 
estimate the doses for the open-ended intervals of exposure or 
intervention doses. When the restricted cubic splines were used to fit 
nonlinear dose-response relationships, there were also no accordant 
criteria to determine the fixed knots. 
What this adds to what was known? 
 A comprehensive appraisal evaluating the reporting characteristics, 
methodological quality, and statistical analysis of published DRMAs 
is imperative but reporting guidelines for DRMAs is lacking. Our 
study has summarized the reported key statistical analysis process, 
which is the important difference between DRMAs and traditional 
meta-analyses. We proposed a brief recommendation to help further 
re-view authors to better conduct DRMAs. 
What is the implication and what should change now? 













specifically for DRMAs. Then there needs to have consistent criteria 
for defining the dose for the open-ended intervals, simultaneously 
needs explicitly fixed knots for assessing restricted cubic splines 
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